✦ LIBER ✦

The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?

✍ Scribed by Per Qvist; Anne-Christine Bay-Jensen; Claus Christiansen; Erik B. Dam; Philippe Pastoureau; Morten A. Karsdal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chondroitin sulfate: S/DMOAD (structure/

✍ Gust Verbruggen; Stefan Goemaere; Eric M. Veys 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 142 KB

OARSI–OMERACT initiative: defining thres

✍ R.L. Manno; C.O. Bingham III; S. Paternotte; L. Gossec; H. Halhol; G. Giacovelli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 406 KB

State-of-the-art disease-modifying osteo

✍ Roland W. Moskowitz; Michele Hooper 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 323 KB

P39 To evaluate the role of disease modi

✍ A Singh; M Jah; B Nandan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Systems to Assess the Progression of Fin

✍ G. Verbruggen; S. Goemaere; E. M. Veys 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 423 KB

Disease modification in osteoarthritis:

✍ Paul Dieppe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB